112 related articles for article (PubMed ID: 17314746)
1. [Investigation of allergic reactions to platinum salts].
Touraine F; Sainte Laudy J; Boumediene A; Ndikumwenayo F; Decroisette C; Melloni B; Vergnenegre A; Bonnaud F
Rev Mal Respir; 2006 Nov; 23(5 Pt 1):458-62. PubMed ID: 17314746
[TBL] [Abstract][Full Text] [Related]
2. Pemetrexed plus cisplatin or pemetrexed plus carboplatin for chemonaïve patients with malignant pleural mesothelioma: results of the International Expanded Access Program.
Santoro A; O'Brien ME; Stahel RA; Nackaerts K; Baas P; Karthaus M; Eberhardt W; Paz-Ares L; Sundstrom S; Liu Y; Ripoche V; Blatter J; Visseren-Grul CM; Manegold C
J Thorac Oncol; 2008 Jul; 3(7):756-63. PubMed ID: 18594322
[TBL] [Abstract][Full Text] [Related]
3. [A case of malignant pleural mesothelioma that responded to cisplatin plus pemetrexed rechallenge].
Shukuya T; Takahashi T; Nakamura Y; Yamamoto N
Gan To Kagaku Ryoho; 2010 Mar; 37(3):487-90. PubMed ID: 20332689
[TBL] [Abstract][Full Text] [Related]
4. Phase I clinical and pharmacokinetic study of pemetrexed and carboplatin in patients with malignant pleural mesothelioma.
Hughes A; Calvert P; Azzabi A; Plummer R; Johnson R; Rusthoven J; Griffin M; Fishwick K; Boddy AV; Verrill M; Calvert H
J Clin Oncol; 2002 Aug; 20(16):3533-44. PubMed ID: 12177114
[TBL] [Abstract][Full Text] [Related]
5. Pemetrexed plus carboplatin or cisplatin as neoadjuvant treatment of operable malignant pleural mesothelioma (MPM).
Pasello G; Marulli G; Polo V; Breda C; Bonanno L; Loreggian L; Rea F; Favaretto A
Anticancer Res; 2012 Dec; 32(12):5393-9. PubMed ID: 23225442
[TBL] [Abstract][Full Text] [Related]
6. A pathological complete response in malignant pleural mesothelioma after combination chemotherapy with Carboplatin and pemetrexed.
Kao SC; McCaughan B; Muljono A; Boyer M
J Thorac Oncol; 2010 Mar; 5(3):405-6. PubMed ID: 20186029
[No Abstract] [Full Text] [Related]
7. [Case of pemetrexed-induced acute lung injury].
Sakamoto S; Kaburaki K; Sakaguchi S; Sano G; Sugino K; Isobe K; Shibuya K; Kurosaki A; Uekusa T; Homma S
Nihon Kokyuki Gakkai Zasshi; 2009 May; 47(5):415-20. PubMed ID: 19514505
[TBL] [Abstract][Full Text] [Related]
8. Single-agent pemetrexed for chemonaïve and pretreated patients with malignant pleural mesothelioma: results of an International Expanded Access Program.
Taylor P; Castagneto B; Dark G; Marangolo M; Scagliotti GV; van Klaveren RJ; Labianca R; Serke M; Schuette W; van Meerbeeck JP; Heigener D; Liu Y; Adachi S; Blatter J; von Pawel J
J Thorac Oncol; 2008 Jul; 3(7):764-71. PubMed ID: 18594323
[TBL] [Abstract][Full Text] [Related]
9. Carboplatin and pemetrexed in the management of malignant pleural mesothelioma: a realistic treatment option?
Li L; Razak AR; Hughes A
Lung Cancer; 2009 May; 64(2):207-10. PubMed ID: 18926592
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of pemetrexed in combination with cisplatin for malignant pleural mesothelioma: a phase I/II study in Japanese patients.
Nakagawa K; Yamazaki K; Kunitoh H; Hida T; Gemba K; Shinkai T; Ichinose Y; Adachi S; Nambu Y; Saijo N; Fukuoka M
Jpn J Clin Oncol; 2008 May; 38(5):339-46. PubMed ID: 18434338
[TBL] [Abstract][Full Text] [Related]
11. Alimta (pemetrexed disodium): a multitargeted antifolate for the treatment of mesothelioma.
Green MR
Lung Cancer; 2002 Nov; 38 Suppl 2():S55-7. PubMed ID: 12431831
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of pemetrexed plus carboplatin in malignant pleural mesothelioma.
Ceresoli GL; Zucali PA; Favaretto AG; Grossi F; Bidoli P; Del Conte G; Ceribelli A; Bearz A; Morenghi E; Cavina R; Marangolo M; Parra HJ; Santoro A
J Clin Oncol; 2006 Mar; 24(9):1443-8. PubMed ID: 16549838
[TBL] [Abstract][Full Text] [Related]
13. Phase I and pharmacokinetic study of pemetrexed plus cisplatin in chemonaive patients with locally advanced or metastatic malignant pleural mesothelioma or non-small cell lung cancer.
Dickgreber NJ; Fink TH; Latz JE; Hossain AM; Musib LC; Thomas M
Clin Cancer Res; 2009 Jan; 15(1):382-9. PubMed ID: 19118069
[TBL] [Abstract][Full Text] [Related]
14. Pemetrexed combination improves mesothelioma survival.
Kerr C
Lancet Oncol; 2005 Aug; 6(8):548. PubMed ID: 16094758
[No Abstract] [Full Text] [Related]
15. Pemetrexed alone or in combination with cisplatin in previously treated malignant pleural mesothelioma: outcomes from a phase IIIB expanded access program.
Jänne PA; Wozniak AJ; Belani CP; Keohan ML; Ross HJ; Polikoff JA; Mintzer DM; Ye Z; Monberg MJ; Obasaju CK;
J Thorac Oncol; 2006 Jul; 1(6):506-12. PubMed ID: 17409909
[TBL] [Abstract][Full Text] [Related]
16. Pemetrexed-cisplatin combination in mesothelioma.
Reck M; Gatzemeier U
Expert Rev Anticancer Ther; 2005 Apr; 5(2):231-7. PubMed ID: 15877521
[TBL] [Abstract][Full Text] [Related]
17. [Malignant pleural mesothelioma: further options].
van Hezik EJ
Arch Bronconeumol; 2005 Dec; 41(12):703. PubMed ID: 16373048
[No Abstract] [Full Text] [Related]
18. Systemic chemotherapy with pemetrexed and cisplatin for malignant peritoneal mesothelioma: a single institution experience.
Lainakis G; Zagouri F; Kastritis E; Sergentanis TN; Bozas G; Dimopoulos MA; Papadimitriou CA
Tumori; 2011; 97(1):25-9. PubMed ID: 21528659
[TBL] [Abstract][Full Text] [Related]
19. Pemetrexed in the treatment of malignant mesothelioma: results from an expanded access program in Germany.
Reck M; Stahel RA; von Pawel J; Karthaus M; Korfee S; Serke M; Schuette WH; Eschbach C; Fink TH; Leschinger MI; Manegold C
Respir Med; 2010 Jan; 104(1):142-8. PubMed ID: 19818589
[TBL] [Abstract][Full Text] [Related]
20. TS, DHFR and GARFT expression in non-squamous cell carcinoma of NSCLC and malignant pleural mesothelioma patients treated with pemetrexed.
Uramoto H; Onitsuka T; Shimokawa H; Hanagiri T
Anticancer Res; 2010 Oct; 30(10):4309-15. PubMed ID: 21036757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]